Plain-English translation of NCT06853626 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new point-of-care blood test called TriageTrue that can measure heart markers in just one hour to help diagnose whether chest pain is caused by a heart attack. The test is done right at the emergency clinic instead of sending patients to the hospital, giving doctors answers much faster. Researchers want to see if this faster diagnosis helps patients get better care while reducing unnecessary hospital referrals.
Right now, many people with chest pain get sent to the hospital because doctors can't quickly tell whether the pain is from a heart attack or something else. This new test aims to give doctors a reliable answer within one hour at the clinic, so patients with non-heart-related chest pain can avoid unnecessary hospitalization and get faster reassurance.
If you qualify, a doctor or nurse at the clinic will take a small blood sample from your arm, which will be tested using the new TriageTrue machine right there at the clinic. You'll wait about one hour for results, and your doctor will use those results to decide whether you need hospital care or can be safely monitored at home. You may also be asked to complete questionnaires about your chest pain, stress, and quality of life during your visit.
AI-generated summary from trial data · Jul 20, 2026 · Not medical advice
Norway